Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$434,114
+$41,547 QoQ
Shares Held
2,770
+7.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#956
of 1,603 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OneAscent Financial Services LLC holds $18,372,386 across 11 Drug Manufacturers - General names. NVS ranks #10 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,312 | $5,171,942 | |
| 2 | JNJ |
Johnson & Johnson
|
13,352 | $3,391,007 | |
| 3 | ABBV |
AbbVie Inc.
|
12,396 | $3,119,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,305 | $1,838,192 | |
| 5 | AMGN |
Amgen Inc
|
3,096 | $1,121,123 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
16,157 | $930,966 | |
| 7 | PFE |
Pfizer Inc
|
37,731 | $908,562 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,618 | $583,438 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $434,114 | 2,770 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $392,567 | 2,570 | Shares | Sole | 2026-04-21 | |
| 2025-06-30 | $260,897 | 2,156 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $253,951 | 2,278 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $212,233 | 2,181 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $253,849 | 2,207 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $238,683 | 2,242 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $223,059 | 2,306 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $228,495 | 2,263 | Shares | Sole | 2024-01-11 | |
| No filing history on record for this holder in this stock. | ||||||